Rheumatoid arthritis sera antibodies to citrullinated collagen type II bind to joint cartilage

[1]  D. van Schaardenburg,et al.  Determining in which pre-arthritis stage HLA-shared epitope alleles and smoking exert their effect on the development of rheumatoid arthritis , 2021, Annals of the Rheumatic Diseases.

[2]  P. Conaghan,et al.  Auto-Antibodies to Post-Translationally Modified Proteins in Osteoarthritis. , 2021, Osteoarthritis and cartilage.

[3]  C. Ge,et al.  Correction to Synthesis of an Array of Triple-Helical Peptides from Type II Collagen for Multiplex Analysis of Autoantibodies in Rheumatoid Arthritis. , 2020, ACS Chemical Biology.

[4]  L. Alfredsson,et al.  Presence of autoantibodies in “seronegative” rheumatoid arthritis associates with classical risk factors and high disease activity , 2020, Arthritis Research & Therapy.

[5]  Kutty Selva Nandakumar,et al.  Cartilage-binding antibodies initiate joint inflammation and promote chronic erosive arthritis , 2020, Arthritis Research & Therapy.

[6]  Kutty Selva Nandakumar,et al.  The autoantibody response to cyclic citrullinated collagen type II peptides in rheumatoid arthritis. , 2019, Rheumatology.

[7]  C. Ge,et al.  The structure, specificity and function of anti-citrullinated protein antibodies , 2019, Nature Reviews Rheumatology.

[8]  Lars E. Borm,et al.  Cartilage-binding antibodies induce pain through immune complex–mediated activation of neurons , 2019, The Journal of experimental medicine.

[9]  Peter Nilsson,et al.  Structural Basis of Cross‐Reactivity of Anti–Citrullinated Protein Antibodies , 2019, Arthritis & rheumatology.

[10]  L. Trouw,et al.  Presence of Autoantibodies in Erosive Hand Osteoarthritis and Association with Clinical Presentation , 2018, The Journal of Rheumatology.

[11]  J. Norris,et al.  Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction , 2018, Nature Reviews Rheumatology.

[12]  T. Huizinga,et al.  The B cell response to citrullinated antigens in the development of rheumatoid arthritis , 2018, Nature Reviews Rheumatology.

[13]  L. Alfredsson,et al.  Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants , 2017, Annals of the rheumatic diseases.

[14]  P. Nilsson,et al.  Anti-citrullinated protein antibodies cause arthritis by cross-reactivity to joint cartilage. , 2017, JCI insight.

[15]  P. Magnusson,et al.  How well do ACPA discriminate and predict RA in the general population: a study based on 12 590 population-representative Swedish twins , 2016, Annals of the rheumatic diseases.

[16]  R. Holmdahl,et al.  Mannan induces ROS-regulated, IL-17A–dependent psoriasis arthritis-like disease in mice , 2014, Proceedings of the National Academy of Sciences.

[17]  Ida E. Andersson,et al.  Type II collagen antibody response is enriched in the synovial fluid of rheumatoid joints and directed to the same major epitopes as in collagen induced arthritis in primates and mice , 2014, Arthritis Research & Therapy.

[18]  R. Holmdahl,et al.  Autoimmune priming, tissue attack and chronic inflammation — The three stages of rheumatoid arthritis , 2014, European journal of immunology.

[19]  Ida E. Andersson,et al.  Identification of New Citrulline‐Specific Autoantibodies, Which Bind to Human Arthritic Cartilage, by Mass Spectrometric Analysis of Citrullinated Type II Collagen , 2014, Arthritis & rheumatology.

[20]  Kutty Selva Nandakumar,et al.  Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis , 2009, The Journal of experimental medicine.

[21]  R. Wait,et al.  Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. , 2008, Arthritis and rheumatism.

[22]  A. Koch.  The pathogenesis of rheumatoid arthritis. , 2007, American journal of orthopedics.

[23]  R. Holmdahl,et al.  Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis , 2005, European journal of immunology.

[24]  L. Alfredsson,et al.  What precedes development of rheumatoid arthritis? , 2004, Annals of the Rheumatic Diseases.

[25]  F. Breedveld,et al.  Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. , 2004, Arthritis and rheumatism.

[26]  E. Lapointe,et al.  Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin , 2004, Arthritis research & therapy.

[27]  Kutty Selva Nandakumar,et al.  Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. , 2003, The American journal of pathology.

[28]  T. Shaw,et al.  B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience , 2003, Annals of the rheumatic diseases.

[29]  Göran Hallmans,et al.  Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[30]  Kutty Selva Nandakumar,et al.  Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. , 2002, Arthritis and rheumatism.

[31]  C. Benoist,et al.  How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease , 2002, Nature Immunology.

[32]  E. Girbal-Neuhauser,et al.  The Major Synovial Targets of the Rheumatoid Arthritis-Specific Antifilaggrin Autoantibodies Are Deiminated Forms of the α- and β-Chains of Fibrin1 , 2001, The Journal of Immunology.

[33]  A. Matsumoto,et al.  Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation. , 2000, Journal of biochemistry.

[34]  M. Jolivet,et al.  The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. , 1999, Journal of immunology.

[35]  R. Holmdahl,et al.  The B cell response to autologous type II collagen: biased V gene repertoire with V gene sharing and epitope shift. , 1996, Journal of immunology.

[36]  R. Dwek,et al.  Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein , 1995, Nature Medicine.

[37]  K. Aho,et al.  Immunopathology of rheumatoid arthritis , 1992 .

[38]  T. Tuomi,et al.  Smoking, lung function, and rheumatoid factors. , 1990, Annals of the rheumatic diseases.

[39]  P. Herberts,et al.  Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. , 1989, Arthritis and rheumatism.

[40]  R. Jonsson,et al.  Demonstration of immunoreactive sites on cartilage after in vivo administration of biotinylated anti-type II collagen antibodies. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[41]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[42]  L. Klareskog,et al.  Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. , 1986, Arthritis and rheumatism.

[43]  V. Duance,et al.  DISAPPEARING COLLAGEN ANTIBODIES IN RHEUMATOID ARTHRITIS , 1985, The Lancet.

[44]  J. Salonen,et al.  When does rheumatoid disease start? , 1985, Arthritis and rheumatism.

[45]  F. Dixon,et al.  Serum transfer of collagen-induced arthritis in mice , 1983, The Journal of experimental medicine.

[46]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[47]  F. V. D. van den Hoogen,et al.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. , 1998, The Journal of clinical investigation.

[48]  K. Aho,et al.  Immunopathology of rheumatoid arthritis. Antikeratin antibodies precede the clinical disease. , 1992, Arthritis and rheumatism.

[49]  R. Altman.  Criteria for the classification of osteoarthritis of the knee and hip. , 1987, Scandinavian journal of rheumatology. Supplement.

[50]  J. Trueta,et al.  Ageing and Osteoarthritis , 1959 .